IBB vs NOBL
iShares Biotechnology ETF vs ProShares S&P 500 Dividend Aristocrats ETF
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
NOBL—
ProShares S&P 500 Dividend Aristocrats ETF
S&P 500 names with 25+ years of dividend growth.
Expense: —Yield: —
Side-by-side metrics
| Metric | IBB | NOBL |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | ProShares |
IBB top holdings
Holdings data unavailable for IBB.
NOBL top holdings
Holdings data unavailable for NOBL.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.
About NOBL
NOBL (ProShares S&P 500 Dividend Aristocrats ETF) is S&P 500 names with 25+ years of dividend growth.